June 2021 Archive
18091.
Spotify acquires Podz, a podcast discovery platform (techcrunch.com)
18092.
Ask HN: How is something like Super.so built?
18093.
Hick's Law or why less is more in UX (easyux.net)
18094.
Ask HN: Why won't GreenHabit succeed? (it's roast time)
18095.
Show HN: Face Profile Generator (aleksimyllyoja.github.io)
18096.
AI-driven robot Mayflower sails back after fault develops (bbc.com)
18097.
Ask HN: Why are some commenters' names green?
18098.
Buyers of Amazon Devices Are Guinea Pigs. That’s a Problem (nytimes.com)
18099.
The Big Tuna Sandwich Mystery (nytimes.com)
18100.
Ask HN: How come we haven't got rid of clickbaits in 2021?
18101.
An interesting way of probing corpi/cultures for bias (spectrum.ieee.org)
18102.
Tesla Model S Plaid – How Fast Can You Get Fast? (drivetribe.com)
18103.
Show HN: Eulogy.io – Generate a loved one's eulogy with GPT-3
18104.
Ask HN: How is Your Experience of Finding Customer Support?
18105.
Ask HN: Finding visa sponsored jobs in US
18106.
Tesla Model S Plaid now uses infrared LEDs for its driver monitoring system (twitter.com)
18107.
Ask HN: GitHub Actions/webhooks broken for you to?
18108.
Have any of you heard about Ukrainian startups and if so, which ones? (ucluster.org)
18109.
The Mammalian Diving Reflex (en.wikipedia.org)
18110.
Ask HN: To what extent is Transhumanism an ideology promoting genocide?
18111.
Why are companies ignorant about copywriting?
18112.
[Ask HN] From days to minutes by using Dask and Spark–what else should I learn?
18113.
Degree over Skills or Skills over Degree? (whoisdeep.com)
18114.
Ask HN: Is Cyber Security a particularly masculine position
18115.
Maybe the Aliens Are Here (scientificamerican.com)
18116.
US gov seized 33 Iranian state linked news sites over alleged disinformation (bloomberg.com)
18117.
How to Tame Your Jax: Navigating TPU VMs with TFRC in 2021 (github.com)
18118.
Ask HN: What's your favorite stack for building local-first apps?
18119.
Show HN: Impaktek: the best way to find a meaningful job (impaktek.fr)
18120.
FDA approved Biogen Alzheimer’s drug despite some objections by staff (marketwatch.com)